NEW YORK, Jan. 29 - RNA interference may be used to stably suppress mammalian gene expression, according to a paper published in the current issue of Proceedings of the National Academy of Sciences.

The research, carried out by scientists at Cold Spring Harbor Laboratory, is also being commercialized as  a high-throughput target validation tool by Genetica, a company founded by Cold Spring researchers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.